Atlas Trials

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Clinical trial NCT05975268 · COMPLETED

Trial details

NCT number
NCT05975268
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Moderate to Severe Chronic Plaque Psoriasis
Start date
2023-08-28
Primary completion
2025-08-20
Enrollment
747

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.